Element Capital Management LLC Adverum Biotechnologies, Inc. Transaction History

Element Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$5.3 - $6.9 $550,670 - $716,910	-103,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $379,235 - $826,005	103,900 New	103,900 $603,000
Q4 2017 Feb 14, 2018	SELL	$2.85 - $3.95 $100,736 - $139,616	-35,346 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$2.45 - $3.65 $218,949 - $326,189	-89,367 Reduced 71.66%	35,346 $129,000
Q2 2017 Aug 14, 2017	BUY	N/A	124,713	124,713 $312,000

2.53M

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $783M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.